diphtheria, tetanus and pertussis vaccine booster (DTcP Booster)
/ CanSino
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 31, 2022
PICTDTOV: Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .
(clinicaltrials.gov)
- P1 | N=400 | Completed | Sponsor: CanSino Biologics Inc. | Unknown status ➔ Completed
Trial completion • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus
1 to 1
Of
1
Go to page
1